|
|
|
|
|
|
|
||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
 |
ABSTRACT |
|---|
 Top ABSTRACT introductionmethodsresultsdiscussionreferences |
|---|
Key Words: submucosal glands • cystic fibrosis • cystic fibrosis transmembrane conductance regulator • sodium bicarbonate cotransporter • serous cells
|
introduction |
|---|
|
TopABSTRACTintroductionmethodsresultsdiscussionreferences |
|---|
). The predominant site of CFTR expression in the human lung is the serous cells of the submucosal glands (Jacquot et al., 1993; Engelhardt et al., 1994). Serous cells account for 60% of the cellular volume of the submucosal gland in human airways (Basbaum et al., 1990). Stimulation of an isotonic fluid secretion from the serous cells contributes to the hydration of the secretions from the mucous cells, thereby forming the low viscosity mucus that lines the conducting airways. Serous cells are also a major source of antimicrobial enzymes and peptides that help maintain an aseptic environment in the lungs (Basbaum et al., 1990). Salt concentration can influence the activity of these antimicrobial agents and it was recently suggested that altered salt concentration in the airway surface fluid may contribute to chronic airway infection in CF (Smith et al., 1996). Thus, the serous cells make a significant contribution to the volume, composition, and consistency of the submucosal gland secretions and represent a potentially important target in CF therapy. These considerations indicate the importance in understanding the mechanisms of fluid and electrolyte transport by serous cells.
Shen et al. (1994) screened 12 cell lines derived from lung adenocarcinomas in an attempt to identify a cell line that displayed electrophysiological properties consistent with human airway serous cells. They identified the Calu-3 cell line as being serous cell in nature, forming a monolayer with a transepithelial resistance of 
100 
· cm2, expressing high levels of CFTR and responding to both cAMP- and Ca2+-mediated agonists with changes in net transepithelial ion transport as measured by short circuit current (Isc) (Finkbeiner et al., 1993; Shen et al., 1994). Several studies have produced variable results in the basal and stimulated transport properties of the Calu-3 cells and the ionic basis of the responses to secretory agonists remains unsettled (Shen et al., 1994; Illek et al., 1997; Moon et al., 1997; Singh et al., 1997; Lee et al., 1998). In this report, we present studies with Calu-3 cells that displayed a low basal Isc (13 µA cm–2) and robust sustained responses to secretory agonists enabling the measurement of isotopic fluxes. The results demonstrate that Calu-3 cells, when stimulated by forskolin, secrete HCO–3 by a Cl –-independent, Na+-dependent, 4,4'-dinitrostilben-2,2'-disulfonic acid (DNDS)–sensitive, electrogenic mechanism. Secondly, when stimulated by 1-ethyl-2 benzimidazolinone (1-EBIO), an activator of the basolateral membrane Ca2+-activated K+ channels (KCa) (Devor et al., 1996), HCO–3 secretion is reduced and the Calu-3 cells secrete predominately Cl – by a bumetanide-sensitive, electrogenic mechanism.
|
methods |
|---|
|
TopABSTRACTintroductionmethodsresultsdiscussionreferences |
|---|
7–14 d, the cells formed a confluent monolayer that held back fluid, thus maintaining an apical air interface. Short circuit current measurements were performed after an additional 14–28 d in culture. Patch-clamp experiments were performed on single cells plated onto glass cover slips 18–48 h before use.
Solutions
For measurements of Isc, the bath solution contained (mM): 120 NaCl, 25 NaHCO3, 3.3 KH2PO4, 0.8 K2HPO4, 1.2 MgCl2, 1.2 CaCl2, and 10 glucose. Mannitol was substituted for glucose in the mucosal solution to eliminate the contribution of Na+ glucose cotransport to ISC as previously reported by Singh et al. (1997). The pH of this solution was 7.4 when gassed with a mixture of 95% O2–5% CO2 at 37°C. For the Cl–-free solution, equimolar Na-gluconate replaced NaCl, 1 mM Mg-gluconate replaced MgCl2, and 4 mM Ca-gluconate replaced CaCl2. Calcium was increased to 4 mM to compensate for the Ca2+ buffering capacity of the gluconate. The HCO–3-free buffer consisted of (mM): 145 NaCl, 3.3 KH 2PO4, 0.8 K2HPO4 1.2 MgCl2, 1.2 CaCl2, 10 HEPES, pH adjusted with NaOH, 10 glucose or mannitol and was gassed with air. For the Na+-free Cl–-free solution, equimolar N-methyl-D-glucamine–gluconate replaced NaCl, choline-HCO3 replaced NaHCO3, 1 mM Mg-gluconate replaced MgCl2, and 4 mM Ca-gluconate replaced CaCl2. This solution contained 10 µM atropine to block the cholinergic effect of choline (Muallem et al., 1988).
The effects of forskolin and 1-EBIO on apical membrane Cl– currents (ICl) were assessed after permeabilization of the serosal membrane with nystatin (360 µg/ml), and the establishment of a mucosa-to-serosa Cl– concentration gradient. Serosal NaCl was replaced by equimolar Na-gluconate and Ca2+ was increased to 4 mM with Ca-gluconate. Nystatin was added to the serosal membrane 15–30 min before the addition of drugs. Successful permeabilization of the basolateral membrane was based upon the recording of a current consistent with the mucosal-to-serosal flow of negative charge. The effect of 1-EBIO on basolateral membrane K+ currents (IK) was assessed after permeabilization of the apical membrane with nystatin (180 µg/ml) for 15–30 min, and establishment of a mucosa-to-serosa K+ concentration gradient. For measurements of IK, mucosal NaCl was replaced by equimolar K-gluconate, while serosal NaCl was substituted with equimolar Na-gluconate. Calcium and Mg2+ salts were replaced as above.
During inside-out patch-clamp recordings, the bath contained (mM): 145 K-gluconate, 5 KCl, 1 MgCl2, 1 EGTA, 0.78 CaCl2, (free Ca2+ = 400 nM), and 10 HEPES, pH adjusted to 7.2 with KOH. The pipette solution contained (mM): 140 K-gluconate, 5 KCl, 1 CaCl2, 1 MgCl2, and 10 HEPES, pH adjusted to 7.2 with KOH. For outside-out recordings, the bath contained 1 mM CaCl2 in the absence of any added EGTA, while the pipette solution Ca2+ was buffered to 200 nM with EGTA (0.71 mM Ca2+, 1 mM EGTA).
Short-Circuit Current (Isc) Measurements
Transwell inserts were mounted in an Ussing chamber (Jim's Instruments). Snapwell inserts were mounted in Ussing chambers (NaviCyte), and the monolayers were continuously short-circuited after fluid resistance compensation using automatic voltage clamps (558C-5; Iowa Bioengineering). Transepithelial resistance (RT) was measured by open-circuiting the monolayer, or with a 2-mV bipolar pulse and the resistance calculated by Ohm's law. Forskolin, 1-EBIO, clotrimazole, 293B, and acetazolamide were added to both sides of the monolayers at the indicated concentrations. Bumetanide and charybdotoxin (CTX) were added only to the serosal bathing solution.
Unidirectional Ion Fluxes
20 min after the Snapwell filters were mounted in Ussing chambers, isotopes (36Cl, 22Na, or 86Rb) were added to the bath solution on one side of the monolayers. After an additional 20 min, by which time isotopic fluxes had reached a steady state, two 0.4-ml samples were taken from the unlabeled side and fresh unlabeled solution of equal volume was added. This time was considered time = 0 (T0), and samples were taken thereafter at 15-min intervals for the next 75 min. When the effects of forskolin, 1-EBIO, or forskolin plus 1-EBIO were studied, the drugs were added to the serosal and mucosal sides at T30 and fluxes before (T0 – T30) and 15 min after the drug additions (T45 – T75) were compared. Isotope activities were determined in a Packard liquid scintillation counter. All samples were weighed and these volumes were used to correct the chamber volume and to calculate the unidirectional ion fluxes using standard equations (Bridges et al., 1983). The net residual ion flux (JRnet) was calculated from the difference in I sc and the net fluxes of Cl–, JClnet; Na+, JNanet; and Rb –, JRbnet, where J Rnet = Isc – (JNanet + 
Rbnet – Clnet ).
Single Channel Recording
Single channel currents were recorded in the inside-out and outside-out patch-clamp recording configuration using a List EPC-7 amplifier (Medical Systems) and recorded on videotape for later analysis as described previously (Devor and Frizzell, 1993). Pipettes were fabricated from KG-12 glass (Willmad Glass Co.). All recordings were done at a holding voltage of –100 mV. The voltage is referenced to the extracellular compartment as the standard method for membrane potentials. Inward currents are defined as the movement of positive charge from the extracellular compartment to the intracellular compartment, and are presented as downward deflections from baseline in all recording configurations.
Single channel analysis was performed on records sampled after low-pass filtering at 400 Hz. Data records for all experimental conditions were at least 60-s long. The nPo (the product of the number of channels, n, and the channel open probability, Po) of the channels was determined using Biopatch software (3.11; Molecular Kinetics). nPo was calculated from the mean total current (I) divided by the single channel current amplitude (i), such that nPo = I/i. i was determined from the amplitude histogram of the current record.
Chemicals
Nystatin was a generous gift from Dr. S. Lucania (Bristol Meyers-Squibb). 293B (trans-6-cyano-4-(N-ethylsulfonyl-N-methylamino)- 3-hydroxy-2,2-dimethyl-chroman) was a generous gift from Dr. Rainer Greger (Albert-Ludwigs-Universtat, Freiberg, Germany). 1-EBIO was obtained from Aldrich Chemical Co. Acetazolamide, clotrimazole, and bumetanide were obtained from Sigma Chemical Co. Forskolin was obtained from Calbiochem. DNDS was from Pfaltz and Bauer. Charybdotoxin was obtained from Accurate Chemical and Scientific Corp. and made as a 10 µM stock solution in standard bath solution. 1-EBIO, 293B, and clotrimazole were made as >1,000-fold stock solutions in DMSO. Nystatin was made as a 180 mg/ml stock solution in DMSO and sonicated for 30 s just before use. Forskolin and bumetanide were made as 1,000-fold stock solutions in ethanol. Cell culture medium was obtained from GIBCO BRL.
Data Analysis
All data are presented as means ± SEM, where n indicates the number of experiments.
|
results |
|---|
|
TopABSTRACTintroductionmethodsresultsdiscussionreferences |
|---|
cm2 (range 187–667 cm2), respectively. Forskolin (2–10 µM) induced, in all filters tested (n = 109), a damped oscillatory response that became stable and sustained after 5–10 min at a plateau value of 66 ± 4 µA · cm–2 (range 50–103 µA · cm–2). A representative current trace is shown in Fig. 1 A. The increase in Isc caused by forskolin was accompanied by a decrease in RT to an average of 189 ± 7 cm–2 (range 111–333 cm–2). Bumetanide (20 µM), an inhibitor of the NaK2Cl cotransporter, caused only a small inhibition of the forskolin stimulated Isc (
–4.9 ± 1.3 µA · cm–2, n = 11). The failure of bumetanide to inhibit the forskolin-stimulated increase in Isc suggests that the NaK2Cl cotransporter does not contribute to the Isc, and this raised the question whether the Isc was due to Cl– secretion. Additional experiments were performed to establish the ionic basis of the forskolin-stimulated Isc.
|
8 µA · cm–2 (i.e., 0.3 µEq · cm–2 · h–1) that was stimulated 6–10-fold by forskolin in the subset of 36 filters used for the flux studies. Under control conditions, there was no net movement of Cl– or Rb+ and a small net absorption of Na+. Forskolin increased both unidirectional fluxes of Cl– four- to fivefold (Fig. 1 B). Both Rb+ fluxes were increased 1.5-fold, but forskolin had no effect on the fluxes of Na+ (Table I). Because both unidirectional fluxes of Cl– and Rb+ were increased to a similar extent, there was no net flux of Cl– or Rb+ caused by forskolin. The difference between Isc and the net flux of each ion was calculated and is given in Table I as JRnet. Because there was no net flux of Cl – or Rb+ under control or forskolin conditions, neither of these ions account for the basal or forskolin-stimulated Isc. However, the net absorption of Na+ fully accounts for the control, basal Isc, and a small portion (15%) of the Isc in the forskolin-stimulated cells. When the flux studies for Cl–, Na+, and Rb+ were combined to calculate theJRnet using the mean Isc (control 0.31 ± 0.053 µEq · cm–2 · h–1; forskolin 2.60 ± 0.144 µEq · cm–2 · h–1, n = 36) for the studies in Table I, the control JRnet was –0.12 ± 0.11 µEq · cm–2 · h–1 and the forskolin JRnet was 2.37 ± 0.189 µEq · cm–2 · h–1. These results demonstrate that the forskolin-induced increase in Isc cannot be accounted for by the net transepithelial secretion of Cl– or the absorption of Na+ or K+. Rather, the increase in Isc caused by forskolin must be attributed to the net movement of an unmeasured ion, often referred to as the net residual ion flux, JRnet. Because HCO–3 is the only remaining ion of significant concentration, J Rnet is likely to be due to the net secretion of HCO–3 and additional experiments were performed to test this hypothesis.
|
0.15 ± 0.76 µA · cm–2, n = 6) (Fig. 3). In contrast, removal of HCO–3 from the mucosal and serosal bathing solutions resulted in a greatly diminished response to forskolin (Fig. 2 B). After a transient response, I sc was increased by only 4 ± 1 µA · cm–2 (n = 10) in HCO–3-free solutions. Substitution of Na + with N-methyl-D-glucamine, Cl– with gluconate, and NaHCO3 with choline HCO3 also resulted in a greatly reduced response to forskolin. Forskolin caused a transient increase in Isc without a sustained plateau in the Na+-free, Cl–-free, HCO–3- containing solution (Fig. 2 C), which resembles the response in HCO–3-free media. However, the subsequent addition of Na + (30 mM) to the serosal but not the mucosal solution caused a sustained increase in Isc of 24 ± 1.0 µA · cm–2 (n = 12) in forskolin-stimulated cells (Fig. 4). Addition of Na+ (30 mM) to the serosal solution be-fore forskolin caused a small decrease in Isc –7.6 ± 0.2 µA · cm–2 (n = 12) as expected for the serosal-to-mucosal diffusion of a cation. This decrease in Isc was reversed and Isc rose to a sustained level of 23 ± 0.8 µA · cm–2 (n = 12) with the subsequent addition of forskolin. Thus, the forskolin-stimulated increase in the Isc was Cl– independent but Na+ and HCO–3dependent.
|
|
|
= 0.2 µA · cm–2, n = 6), but caused an inhibition of 56% ( –26 ± 1 µA · cm–2, n = 6) when added to the serosal side in Cl–-free solutions. Similar results were obtained in Cl–-containing solutions ( –2.5 ± 1.3 µA · cm–2, n = 6 mucosal; –27 ± 2 µA · cm–2, n = 6 serosal). The half maximal inhibitory concentration (Ki) for serosal DNDS was 300 µM. The inhibitory effects of serosal DNDS and acetazolamide were additive, together causing a 75% decrease in Isc. The Na+-K+-ATPase inhibitor, ouabain (100 µM), caused an immediate and complete inhibition of the forskolin-stimulated Isc. Neither CTX (50 nM), a blocker of Ca2+ activated K+ channels (Garcia et al., 1995), nor 293B (100 µM), a blocker of the cAMP/ PKA activated K+ channel (KvLQT1; Lohrmann et al., 1995; Loussouarn et al., 1997) inhibited the forskolin-stimulated Isc. The nonselective K+ channel blocker, Ba2+ (5 mM serosal side), inhibited the forskolin-stimulated Isc by only 10 ± 2 µA · cm–2 (n = 6). The requirement for serosal Na+, the inhibition by ouabain, and the partial inhibition by serosal DNDS suggests some of the secreted HCO–3 is mediated by the uptake of HCO–3 across the basolateral membrane on a Na +:HCO–3 cotransporter. 2 The partial inhibition of Isc by acetazolamide suggests some of the secreted HCO–3 originates from a metabolic source. The Cl – independence and the failure of mucosal DNDS to inhibit Isc suggests the exit of HCO–3 across the apical membrane is not mediated by a Cl –/HCO–3 exchanger.
pH Studies
The above results are consistent with the conclusion that forskolin stimulation causes the electrogenic secretion of HCO–3. To further test this hypothesis, we performed experiments to determine whether forskolin caused an alkalinization of the apical solution. Calu-3 cells were studied under open circuit conditions with a small volume of fluid (100 µl) on the apical surface (1.1 cm2) and 5 ml of continuously gassed (95% O2/ 5% CO2) NaCl, NaHCO3 buffer, pH 7.4, on the serosal side. Cells were incubated without or with forskolin (2 µM) and the apical solution collected after 90 min. The apical sample was thoroughly gassed before measuring its pH with a miniature pH electrode. Studied in this manner, we found forskolin caused an alkalinization of the apical solution to a pH of 7.8 ± 0.06 (n = 6), whereas control untreated filters showed a small acidification of the apical solution, pH 7.3 ± 0.05 (n = 6). The forskolin-stimulated alkalinization of 0.5 pH over a 90-min period corresponds to the net movement of HCO–3 of 1.7 µeq · cm–2 · h–1 or 46 µA · cm–2, a value in good agreement with the forskolin-stimulated increase in Isc of 53 µA · cm–2 under short circuit conditions.3 Based on these pH measurements, the ion flux measurements, the ion substitution studies, and the pharmacology studies, we conclude that the forskolin-induced Isc response in Calu-3 cells is due to the net secretion of HCO–3 by a Cl –-independent Na+-dependent, and DNDS-sensitive electrogenic mechanism.
Effects of 1-EBIO on Calu-3 Cells
We previously demonstrated that the novel benzimidazolinone, 1-EBIO, induced a sustained transepithelial Cl– secretory response in rat colonic mucosa, human colonic T84 cells, and murine airway epithelia (Devor et al., 1996). CTX and clotrimazole inhibited the 1-EBIO– stimulated Cl– secretion consistent with the activation of basolateral membrane K+ channels that was confirmed in permeabilized monolayers (Devor et al., 1996, 1997). Moreover, patch clamp studies demonstrated 1-EBIO activates an inwardly rectifying, calcium activated, CTX, and clotrimazole-sensitive K+ channel (Devor et al., 1996, 1997). Permeabilized monolayers revealed 1-EBIO also activates an apical membrane Cl– conductance (Devor et al., 1996). The studies reported here were performed to determine if 1-EBIO would have similar effects on Calu-3 cells.
In 46 experiments, 1-EBIO (1 mM) increased Isc from a basal value of 8 ± 0.8 to 62 ± 4 µA · cm–2 with only a modest decrease in RT (control 397 ± 21 cm2 vs. 1-EBIO 336 ± 20 cm2). A current trace of a typical Isc response to 1-EBIO is shown in Fig. 5 A. The response was rapid in onset and sustained over a long period. Dose–response studies revealed the half maximal effective concentration of 1-EBIO was 500 µM. Consistent with the activation of the KCa channels, CTX (50 nM) inhibited 47% of the 1-EBIO–stimulated Isc. The half maximal effective concentration of CTX was 3.2 nM (n = 4). Clotrimazole (10 µM), a nonpeptide inhibitor of KCa, also inhibited 87.6 ± 1.9% (n = 5) of the response to 1-EBIO with a K i of 1.2 µM (n = 5). Bumetanide (20 µM) inhibited 50% of the 1-EBIO–stimulated Isc (Table II). DNDS and acetazolamide caused only small (<10%) decreases in the 1-EBIO–stimulated Isc.
|
|
Effects of Forskolin and 1-EBIO on Isc
The above results demonstrate Calu-3 cells secrete HCO–3 when stimulated by forskolin and Cl – when stimulated by 1-EBIO. In the next series of experiments, we evaluated the effects of 1-EBIO on forskolin stimulated monolayers. As in the previous experiments, forskolin increased Isc from a control value of 6.8 ± 0.7 to 67 ± 4.3 µA · cm–2 (n = 12) without causing the net secretion of Cl– and leaving a JRnet nearly equal to the change in I sc (Fig. 6 and Table III). 1-EBIO further increased Isc to 114 ± 5 µA · cm–2 (Fig. 6 and Table III). Similar results were obtained if the order of the addition of forskolin and 1-EBIO were reversed. CTX inhibited 79 ± 2% (n = 8) and bumetanide inhibited 80 ± 1% (n = 5) of the forskolin plus 1-EBIO–stimulated Isc. When added to the forskolin-stimulated cells, 1-EBIO caused a twofold increase in the serosal-to-mucosal flux of Cl– and a J Cl–net that was nearly equal to the I sc (Fig. 6 and Table III). Thus, 1-EBIO caused a 70% decrease in the forskolin-stimulated JRnet. These results suggest 1-EBIO can switch the forskolin-stimulated Calu-3 cells from HCO–3- to Cl –-secreting cells.
|
|
). A second hypothesis, and one that is not mutually exclusive with the former hypothesis, is that 1-EBIO activates apical membrane anion channels that were not activated by forskolin and that the 1-EBIO-activated channels allow for the preferential exit of Cl– over HCO–3. To test these hypotheses, we performed studies on permeabilized monolayers.
The pore forming antibiotic nystatin was used to permeabilize the apical membrane and a transepithelial mucosal-to-serosal K + gradient was established. After permeabilization, 1-EBIO increased IK, and this was inhibited by both CTX (Fig. 7 A) and clotrimazole (B). In 17 experiments, 1-EBIO (1 mM) increased IK an average of 91 ± 9 µA · cm–2 and this was inhibited 66 ± 2% by CTX (50 nM, n = 10) and 95 ± 2% by clotrimazole (10 µM, n = 7). Thus, 1-EBIO does activate basolateral membrane K+ channels. In contrast, forskolin (2 µM) failed to cause an increase in IK. After the establishment of a mucosal-to-serosal Cl– gradient, the addition of nystatin to the serosal membrane elicited an absorptive ICl of 58 ± 9 µA · cm–2 (n = 24, Fig. 8). Thus, in contrast to the measurements of IK, treatment of the monolayers with nystatin appears to uncover or activate a substantial basal ICl. Similar results were observed in T84 cells studied under the same experimental conditions (Devor et al., 1996). Therefore, this effect of nystatin is not unique to Calu-3 cells. The mechanisms involved in this nystatin induced increase in ICl are unknown. The subsequent addition of forskolin (10 µM) to the nystatin-treated monolayers increased ICl by an additional 186 ± 15 µA · cm–2 (n = 7) (Fig. 8 A). 1-EBIO failed to cause any further increase in ICl in the forskolin treated monolayers. However, 1-EBIO alone when added to the nystatin-treated monolayers increased ICl by an additional 74 ± 11 µA · cm–2 (n = 6) and forskolin further increased ICl by an additional 110 ± 12 µA · cm–2 (n = 6; Fig. 8 B).
|
|
) prevents us from determining whether the same channel or different Cl– channels are activated by forskolin and 1-EBIO. However, when forskolin and then 1-EBIO was added, the effects on ICl were not additive, suggesting that forskolin alone can maximally activate the apical Cl– conductance. Therefore, the effect of 1-EBIO in causing the switch from HCO–3 secretion to Cl – secretion appears to result from the activation of basolateral membrane K+ channels and decreased driving force for HCO–3 entry across the basolateral membrane. This hypothesis will be considered further in the discussion.
Excised Patch Single Channel Records
The above results indicate that Calu-3 cells express K + channels with similar pharmacological characteristics to the K+ channels we described previously in T84 cells (Devor and Frizzell, 1993; Devor et al., 1996, 1997) and that this conductance may be important in altering the driving force for HCO–3 entry across the basolateral membrane that elicits Cl – secretion in Calu-3 cells. Thus, we wished to characterize this K+ channel at the single channel level. Inward and outward single-channel currents observed on excision of membrane patches into a symmetric K+ bath containing 400 nM free Ca2+ are shown in Fig. 9 A. Channel activity showed no obvious voltage dependence and required Ca2+ in the bath (data not shown). The average current–voltage for four such patches is shown in Fig. 9 B (•). Single channel currents were inwardly rectified with average chord conductance values of 31 ± 2 pS at –100 mV and 9 ± 0.2 pS at +100 mV. The K+-to-Na+ selectivity of this channel was assessed by replacing 100 mEq pipette K+ with Na+; PK/PNa was calculated from the Goldman-Hodgkin-Katz relation. Replacing pipette K+ with Na+ shifted the reversal potential by –20 mV (n = 4; Fig. 9 B, 
). A shift of –27 mV is predicted for a perfectly K+ selective electrode. From these data, the calculated K+-to-Na+ selectivity ratio is 5.5:1. This conductance and K+:Na+ selectivity values are similar to what has been previously reported for a Ca2+-activated K+ channel in T84 cells (Devor and Frizzell, 1993; Tabcharani et al., 1994; Roch et al., 1995) as well as primary cultures of canine tracheal epithelial cells (Welsh and McCann, 1985; McCann et al., 1990).
|
). Thus, we determined whether 1-EBIO would similarly activate KCa in excised, inside-out single channel patch-clamp recordings from Calu-3 cells. The effect of 1-EBIO (200 µM) on one patch is shown in Fig. 10. Under control conditions (400 nM free Ca2+ in the bath), minimal KCa channel activity was observed. 1-EBIO produced a large increase in channel activity that was readily reversible after washout of the 1-EBIO. In 14 inside-out recordings, 1-EBIO increased nPo from 0.08 ± 0.02 to 1.68 ± 0.39. These results indicate that this channel, as in T84 cells, is responsible for the increase in the basolateral membrane K+ conductance and Isc during an 1-EBIO–mediated secretory response.
|
|
|
discussion |
|---|
|
TopABSTRACTintroductionmethodsresultsdiscussionreferences |
|---|
Although forskolin did not stimulate the net secretion of Cl–, it did cause a fivefold increase in both unidirectional fluxes of Cl– (Fig. 1 B and Table I) and it is of interest to understand the mechanisms that underly these changes. Our first interpretation was that forskolin increased the transcellular passage of Cl– in both directions. Thus, the opening of CFTR would allow for both the exit and entry of Cl– across the apical membrane. The NaK2Cl cotransporter in the basolateral membrane would allow the entry of Cl– leaving one to explain how Cl– exits the cell in the serosal-to-mucosal direction. However, bumetanide did not alter the unidirectional fluxes, consistent with the lack of change in the forskolin-stimulated Isc. Thus, the NaK2Cl cotransporter does not appear to mediate the entry of Cl– across the basolateral membrane in the forskolin-stimulated monolayers. We next entertained the possibility that Cl– may move across the basolateral membrane on a Cl–:HCO–3 exchanger. However, the increases in both unidirectional fluxes in response to forskolin were still observed in HCO–3-free buffer. Thus, the increased fluxes do not depend on extracellular HCO–3. Because this experiment does not exclude the possibility that a basolateral membrane anion exchanger is operating in a Cl –:Cl– exchange mode, we examined the effects of serosal DNDS (1 mM) on the Cl– fluxes. DNDS cause a 70% decrease in both unidirectional fluxes in the forskolin-stimulated monolayers. Therefore, the increase in Cl– fluxes caused by forskolin can largely be accounted for by a Cl–:Cl– exchange across the basolateral membrane and the exit and entry of Cl– via CFTR across the apical membrane.
The studies with 1-EBIO demonstrated the Calu-3 cells are not limited to the secretion of HCO–3 , but rather they can also be stimulated to secrete Cl–. 1-EBIO, like forskolin, consistently caused a sustained increase in Isc. 36Cl flux studies showed the 1-EBIO–stimulated increase in Isc could be fully accounted for by the net secretion of Cl–. In addition, both the increase in Isc and the net secretion of Cl– were inhibited by bumetanide. Studies on permeabilized Calu-3 monolayers revealed 1-EBIO activates both a basolateral membrane K+ conductance and an apical membrane Cl– conductance as previously shown in studies on T84 cells (Devor et al., 1996). CTX and clotrimozole both inhibited the 1-EBIO Isc response as well as the 1-EBIO–activated K+ current in permeabilized monolayers. Patch-clamp studies demonstrated the presence of an intermediate conductance, inwardly rectified, Ca+-activated K+ channel in Calu-3 cells that was activated by 1-EBIO and blocked by CTX and clotrimozole. We and others have also identified a Ca+-activated K+ channel with identical biophysical properties and pharmacological profile in T84 cells (Devor and Frizzell, 1993; Tabcharani et al., 1994; Roch et al., 1995; Devor et al., 1996). Moreover, Welsh and McCann (1985) and McCann et al. (1990) have already shown that this channel is expressed in native airway epithelial cells and is therefore not just in epithelial cell lines. Recently, three different groups have cloned the same K+ channel, variously referred to as hIK-1, hSK4, and hIK (Ishii et al., 1997; Joiner et al., 1997; Jensen et al., 1998). These channels have identical biophysical properties and pharmacological profile to the channel observed in canine tracheocytes, T84 cells, and Calu-3 cells. Northern blot analysis has confirmed the presence of the mRNA for hIK-1 in T84 and Calu-3 cells (Devor, D.C., unpublished results). Thus, we conclude that one site of action of 1-EBIO is the activation of hIK-1 in the basolateral membrane of Calu-3 cells. Permeabilization of monolayers demonstrated 1-EBIO also activates an apical membrane Cl– channel; however, the identity of the apical membrane Cl– channel that is activated by 1-EBIO is less certain. Haws et al. (1994) have reported the predominant Cl– channel observed in Calu-3 cells is a low conductance channel with properties consistent with those of CFTR. 1-EBIO is a benzimidazolinone and other benzimidazolinones (e.g., NS004 and NS1619) have been reported to activate CFTR (Gribkoff et al., 1994; Champigny et al., 1995). Thus, it is possible that the Cl– channel activated by 1-EBIO in Calu-3 cells is CFTR. However, further studies will be necessary to confirm this hypothesis.
Calu-3 cells secrete HCO–3 in response to forskolin and Cl – in response to 1-EBIO. However, when the two agonists are added together, anion secretion is dominated by Cl– secretion and there is a decrease in the net secretion of HCO–3. Studies with primary cultures of human bronchial epithelial cells lead Smith and Welsh (1992) to suggest that airway epithelia may also switch between HCO–3 and Cl – secretion. Ashton et al. (1991) have also suggested that pancreatic ductal epithelial cells can be differentially stimulated to secrete HCO–3 or Cl–. The mechanisms that underlie the switch between HCO–3 and Cl – secretion are largely unknown. Our results with Calu-3 cells offer some insight and suggest a model (Fig. 12) to explain how the same cell can secrete HCO–3 when stimulated by forskolin and Cl – when stimulated by 1-EBIO or 1-EBIO plus forskolin.
|
; Shen et al., 1994) and activated by forskolin when measured by anion efflux methods and patch clamp analysis (Haws et al., 1994). Preliminary studies using impedance analysis have shown forskolin does activate an apical membrane anion conductance in Calu-3 cells (Bridges, R.J., unpublished observations). Patch-clamp anion selectivity studies have shown CFTR can conduct HCO–3, although at a fraction (0.15–0.25) of the Cl – conductance (Gray et al., 1990; Poulsen et al., 1994; Linsdell et al., 1997). Heterologous expression of wt-CFTR but not F508-CFTR in NIH3T3 fibroblasts and C127 mammary cells was shown to confer the cells with a Na+-independent, HCO–3-dependent, forskolin-regulated intracellular pH recovery mechanism (Poulsen et al., 1994). Illek et al. (1997) have shown, in 
-toxin– permeabilized monolayers of Calu-3 cells, the activation of a HCO–3 current by cAMP with a similar HCO–3 to Cl – selectivity as observed in the patch-clamp studies. In addition, Smith and Welsh (1992) demonstrated cAMP-stimulated HCO–3 secretion across normal but not CF airway epithelia and they suggested HCO–3 exit across the apical membrane is through the Cl – channel that is defectively regulated in CF. Thus, we propose that CFTR mediates the exit of HCO–3 across the apical membrane of Calu-3 cells.
The involvement of an anion channel in HCO–3 secretion is not a new concept. However, previous models have proposed the anion channel acts as a shunt pathway mediating the exit of Cl– from the cell (Stetson et al., 1985). Luminal Cl– is then thought to be used by an apical membrane Cl–:HCO–3 exchanger that mediates the exit of HCO–3 from the cell. Thus, this model for HCO–3 secretion necessitates the presence of luminal Cl – for the apical membrane exit of HCO–3. The studies with Calu-3 cells demonstrate Cl – is not required for the secretion of HCO–3. Ishiguro et al. (1996) have recently reported results on HCO–3 secretion in interlobular ducts from guinea pig pancreas that demonstrate agonist-stimulated HCO–3 efflux at low (7 mM) luminal Cl – concentrations. These authors suggest their results are not easily reconciled with HCO–3 transport across the luminal membrane being mediated by a Cl –:HCO–3 exchanger in parallel with a Cl – conductance. Rather, they too argue for a conductive, channel mediated, exit of HCO–3 across the apical membrane (Ishiguro et al., 1996). Our findings are consistent with this hypothesis, and they suggest the Calu-3 cells will be a useful cell line to help further test this hypothesis as well as to determine the role of CFTR in apical HCO–3 exit.
The second tenet of the model (Fig. 12) is the presence of an electrogenic Na +:HCO–3 cotransporter (NBC) in the basolateral membrane that mediates the entry of HCO–3 into the cell. Boron and Boulpaep (1983) were the first to describe an electrogenic NBC with Na +:HCO–3 stoichiometry of 1:3 that mediates the exit of HCO–3 across the basolateral membrane in the proximal tubule of the tiger salamander Ambystoma tigrinum. Romero et al. (1997) using mRNA from the tiger salamander kidney have recently expression cloned this NBC. The cloning of a human homologue of the renal NBC has also recently been reported (Burnham et al., 1997), as has a unique human pancreatic isoform (Abuladze et al., 1998). The stoichiometries of the cloned NBCs have not yet been established but Xenopus oocyte expression studies have shown the renal NBC is electrogenic, Na+- and HCO–3-dependent, Cl –-independent, and disulfonic stilbene–sensitive (Romero et al., 1997). These characteristics are shared by NBCs studied in kidney, glial, liver, pancreas, and colon (Boron and Boulpaep, 1989). Our studies with Calu-3 cells demonstrate that forskolin-stimulated HCO–3 secretion also shares these characteristics, consistent with the presence of a NBC in the basolateral membrane. Preliminary reverse transcription–PCR and sequencing studies have shown Calu-3 cells express a NBC (Gangopadhyay and Bridges, unpublished observations) lending further support to this notion. Studies in progress are focused on ascertaining which of the NBC isoforms is expressed in Calu-3 cells as well as the membrane localization, apical versus basolateral, of the cotransporter. According to Fig. 12, we predict a basolateral membrane NBC with a Na +:HCO–3 stoichiometry that favors the entry of HCO–3 when Calu-3 cells are stimulated by forskolin. Both the pancreatic and renal isoforms of the NBCs have consensus phosphorylation sites for protein kinase A and therefore may be regulated by cAMP-mediated agonists (Romero et al., 1997; Abuladze et al., 1998). Thus, in addition to the activation of an apical membrane anion channel (CFTR?), forskolin may also activate HCO–3 entry on the NBC.
Whether a NBC mediates entry or exit of HCO–3 depends on the stoichiometry of the transporter, the membrane potential, and the concentrations of Na + and HCO–3 inside and outside the cell. Sodium: HCO–3 stoichiometries of 1:2 and 1:3 have been reported (Boron and Boulpaep, 1989), indicating that turnover of the NBC may result in the transfer of one or two negative charges across the membrane at usual membrane voltages. The 1:2 stoichiometry is associated with NBC-mediated HCO–3 entry, whereas a 1:3 stoichiometry is consistent with HCO–3 exit. If one assumes typical ion concentrations of 145 mM Na +, 25 mM HCO–3 outside, and 15 mM Na + and 15 mM HCO–3 inside, then HCO–3 will enter a cell on the NBC at membrane potentials less hyperpolarized than –85 mV when the Na+:HCO–3 stoichiometry is 1:2 and –49 mV when it is 1:3. Membrane potentials more hyperpolarized than these valves will lead to HCO–3 exit from the cells. Thus, the activation of basolateral membrane K + channels by 1-EBIO is expected to hyperpolarize the membrane potential, and this will inhibit the entry of HCO–3 on the NBC. If the hyperpolarization is of sufficient magnitude, this change in driving force may drive HCO–3 out of the cell across the basolateral membrane. Hyperpolarization will also tend to drive anions (HCO–3 and Cl–) out of the cell across the apical membrane. However, because basolateral membrane entry of HCO–3 becomes inhibited, this apical membrane hyperpolarization will favor Cl– secretion. Therefore, we propose that the switch between HCO–3 secretion and Cl – secretion is determined by the basolateral membrane potential. Differential regulation of the basolateral membrane potential by secretory agonists would provide a means of stimulating HCO–3 or Cl – secretion. As shown in Fig. 12, CFTR could serve as both a HCO–3 and a Cl – channel mediating the apical membrane exit of either anion depending on the nature of the anion provided by the basolateral membrane cotransporter mechanisms.
Why does forskolin fail to stimulate Cl– secretion in Calu-3 monolayers? Cyclic AMP–stimulated Cl– secretion is known to require the activation of both an apical membrane Cl– conductance and a basolateral membrane K+ conductance; the former depolarizes and the latter repolarizes the membrane voltage to maintain a driving force for Cl– exit (Halm and Frizzell, 1990). Permeabilization studies demonstrated forskolin does activate an apical membrane Cl– conductance (Fig. 8), but that it fails to activate a basolateral membrane K+ conductance (Fig. 7). Thus, unless the basal K+ conductance can maintain the apical voltage above the Cl– equilibrium potential (ECl < –35 mV, assuming intracellular Cl– = 30 mM), Cl– can not be secreted. Indeed, the expected high Cl– conductance of the apical membrane of forskolin-stimulated Calu-3 cells would set the apical membrane voltage at ECl and this would provide the driving force for HCO–3 exit since E HCO3 is –13 mV (assuming intracellular HCO–3 = 15 mM and extracellular = 25 mM).4 This electrical coupling may explain the apparent Cl– dependence of HCO–3 secretion in some epithelia and further emphasizes the importance of CFTR in Cl – and HCO–3 secretion.
If the results we have obtained with Calu-3 cells accurately reflect the transport properties of native submucosal gland serous cells, then HCO–3 secretion in the human airways warrants greater attention. Calu-3 cell HCO–3 secretion in response to cAMP-mediated agonists is quite similar to that observed in pancreatic duct cells where mutations in CFTR have profound pathological effects. Pancreatic function in CF patients is characterized by impaired fluid, HCO–3, and Cl – secretion by the ductal epithelial cells, the site of CFTR expression (Durie and Forstner, 1989; Marino et al., 1991). Impaired secretion ultimately leads to destruction of the pancreas by digestive enzymes in the obstructed ducts. The principle secreted ion by the ductal cells is HCO–3, which drives Na + and water into the lumen by electrical and osmotic coupling. The secreted alkaline fluid serves to regulate the activities of the digestive enzymes and to flush them into the duodenal lumen. Secreted HCO–3 is also thought to have an osmotic advantage (Hogan et al., 1994). With the aid of carbonic anhydrase, HCO–3 can quickly combine with protons to make CO 2 and H2O, and thereby tend to make the fluid hypoosmotic. If the airway submucosal glands and surface epithelium function in an analogous manner, potential roles for HCO–3 in the airways may include the processing, regulation, and clearance of submucosal gland–derived enzymes, mucus, and antimicrobial agents. Early studies have suggested mucus undergoes a transition from gel to sol at alkaline pH (Forstner et al., 1977) and HCO–3 secretion could therefore aid in the clearance of mucus from the submucosal glands, a process that is impaired in CF. Airway serous cells also express abundant amounts of carbonic anhydrase (Basbaum et al., 1990), some of which may be of the type IV membrane-associated isoform that could convert the secreted HCO–3 to CO2 and H2O in the lumen of the gland or in the airway surface fluid. The rapid loss of CO2 during ventilation of the airways would favor a shift in the enyzmatic equilibrium toward the conversion of HCO–3 to H2O. The volatility of the HCO–3 /CO2 buffer system, especially at an air–liquid interface, while having potential physiological significance, will also make the investigation of HCO–3 secretion in the airways a formidable challenge to the experimentalist. Studies with Calu-3 cells will provide a means to further investigate the mechanisms involved in serous cell HCO–3 secretion, and perhaps with this knowledge how to better study HCO–3 secretion in the intact airways.
2 White (1989)
has reported a complete inhibition by 1 mM DNDS of a Na+:HCO–3 cotransporter in the basolateral membrane of salamander intestine. Newman (1991) has reported a 73% inhibition by 2 mM DNDS of a Na+:HCO–3 cotransporter in retinal glial cells of the salamander. Although perhaps not directly comparable, Boron and Knakal (1989) reported a DNDS Ki of 300 µM of a Na+- and Cl–- dependent HCO–3 cotransporter in the squid axon. 
3 The net secretion of HCO–3 can be calculated from the equation J (mol · cm–2 · h–1) = buffer capacity (βCO2) · pH · h–1 · volume · area–1, where βCO2 = 2.3 (25 mM HCO–3 ), final volume = 100 µl, and area = 1.1 cm2. Thus, JHCO3 = 57.5 · 0.33 pH · h–1 · 0.1 x 10–3 liters · 1.1 cm–2 = 1.7 µeq · cm–2 · h–1. Although the final volume was not measured, it was consistently greater in the forskolin-stimulated monolayers compared with the control monolayers. Therefore, the actual net flux of HCO–3 would be proportionally higher and be in even closer agreement with the forskolin-stimulated increase in Isc.
4 Together with the measured net secretion of HCO–3 of 60 µA · cm–2, one can use the values for EHCO3 (–13 mV) and ECl (–35 mV) to obtain an estimate of the apical membrane HCO–3 conductance (gHCO3), where gHCO3 = (ECl – EHCO3)/IHCO3 = 2.7 mS · cm–2. This estimation assumes the apical membrane is at ECl. Results from impedance analysis on Calu-3 cells indicate forskolin increases the apical membrane conductance (gapical) to 20 mS · cm–2 (Bridges, R.J., unpublished observations). This remarkably high conductance would ensure the apical membrane potential is at or near ECl, but also yields a HCO–3 to Cl– conductance ratio of 0.15 (where gCl = gapical – gHCO3 = 20 – 2.7 = 17.3 mS · cm–2 so that gHCO3/gCl = 2.7/17.3 = 0.15), a value in good agreement with the patch clamp estimates of 0.15–0.25 for CFTR. Moreover, an apical membrane gCl of 17.3 mS · cm–2 means a driving force of only 3.5 mV is required to achieve a net Cl– secretion of 60 µA · cm–2.
|
ACKNOWLEDGMENTS |
|---|
This work was supported by Cystic Fibrosis Foundation (CFF) grant Devor96PO (to D.C. Devor) and National Institute of Diabetes and Digestive and Kidney Disease grants DK45970 (to R.J. Bridges) and DK46588 (to R.A. Frizzell). A.C. DeLuca is a CFF fellow (DeLuca98DO) and R.J. Bridges is a CFF Research Scholar (E841).
Submitted: 22 December 1998
Accepted: 9 March 1999
|
references |
|---|
|
TopABSTRACTintroductionmethodsresultsdiscussionreferences |
|---|
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  C. A. Bertrand, R. Zhang, J. M. Pilewski, and R. A. Frizzell SLC26A9 is a constitutively active, CFTR-regulated anion conductance in human bronchial epithelia J. Gen. Physiol., April 1, 2009; 133(4): 421 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ishiguro, M. C. Steward, S. Naruse, S. B.H. Ko, H. Goto, R. M. Case, T. Kondo, and A. Yamamoto CFTR Functions as a Bicarbonate Channel in Pancreatic Duct Cells J. Gen. Physiol., March 1, 2009; 133(3): 315 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Kreindler, C. A. Bertrand, R. J. Lee, T. Karasic, S. Aujla, J. M. Pilewski, R. A. Frizzell, and J. K. Kolls Interleukin-17A induces bicarbonate secretion in normal human bronchial epithelial cells Am J Physiol Lung Cell Mol Physiol, February 1, 2009; 296(2): L257 - L266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Matsuno, Y. Ito, T. Ohashi, M. Morise, N. Takeda, K. Shimokata, K. Imaizumi, H. Kume, and Y. Hasegawa Dual Pathway Activated by tert-Butyl Hydroperoxide in Human Airway Anion Secretion J. Pharmacol. Exp. Ther., November 1, 2008; 327(2): 453 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Wang, Y. Sun, W. Zhang, and P. Huang Apical adenosine regulates basolateral Ca2+-activated potassium channels in human airway Calu-3 epithelial cells Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1443 - C1453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tamada, M. Nara, H. Kanatsuka, M. Nagaoka, R. Koshida, G. Tamura, and T. Hattori A Potentiating Effect of Endogenous NO in the Physiologic Secretion from Airway Submucosal Glands Am. J. Respir. Cell Mol. Biol., September 1, 2007; 37(3): 357 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Liu and J. M. Farley Sr. Prostaglandin E2 Enhances Acetylcholine-Induced, Ca2+-Dependent Ionic Currents in Swine Tracheal Mucous Gland Cells J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 501 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Quinton Cystic Fibrosis: Lessons from the Sweat Gland Physiology, June 1, 2007; 22(3): 212 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Moser, A. Gangopadhyay, N. A. Bradbury, K. W. Peters, R. A. Frizzell, and R. J. Bridges Electrogenic bicarbonate secretion by prairie dog gallbladder Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1683 - G1694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kodric, A. N. Shah, L. M. Fabbri, and M. Confalonieri An Investigation of Airway Acidification in Asthma Using Induced Sputum: A Study of Feasibility and Correlation Am. J. Respir. Crit. Care Med., May 1, 2007; 175(9): 905 - 910. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Ianowski, J. Y. Choi, J. J. Wine, and J. W. Hanrahan Mucus secretion by single tracheal submucosal glands from normal and cystic fibrosis transmembrane conductance regulator knockout mice J. Physiol., April 1, 2007; 580(1): 301 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Lamprecht and U. Seidler The emerging role of PDZ adapter proteins for regulation of intestinal ion transport Am J Physiol Gastrointest Liver Physiol, November 1, 2006; 291(5): G766 - G777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ohashi, Y. Ito, T. Matsuno, S. Sato, K. Shimokata, and H. Kume Paradoxical Effects of Hydrogen Peroxide on Human Airway Anion Secretion J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 296 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Carlin, R. L. Sedlacek, R. R. Quesnell, F. Pierucci-Alves, D. M. Grieger, and B. D. Schultz PVD9902, a porcine vas deferens epithelial cell line that exhibits neurotransmitter-stimulated anion secretion and expresses numerous HCO3- transporters Am J Physiol Cell Physiol, June 1, 2006; 290(6): C1560 - C1571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Palmer, S. Y. Lee, P. J. Maniak, D. Carlson, S. C. Fahrenkrug, and S. M. O'Grady Protease-activated receptor regulation of Cl- secretion in Calu-3 cells requires prostaglandin release and CFTR activation Am J Physiol Cell Physiol, April 1, 2006; 290(4): C1189 - C1198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Wine Acid in the airways. Focus on "Hyperacidity of secreted fluid from submucosal glands in early cystic fibrosis" Am J Physiol Cell Physiol, March 1, 2006; 290(3): C669 - C671. [Full Text] [PDF]
|
|
|
|
|
|
Y. Song, D. Salinas, D. W. Nielson, and A. S. Verkman Hyperacidity of secreted fluid from submucosal glands in early cystic fibrosis Am J Physiol Cell Physiol, March 1, 2006; 290(3): C741 - C749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Swiatecka-Urban, S. Moreau-Marquis, D. P. MacEachran, J. P. Connolly, C. R. Stanton, J. R. Su, R. Barnaby, G. A. O'Toole, and B. A. Stanton Pseudomonas aeruginosa inhibits endocytic recycling of CFTR in polarized human airway epithelial cells Am J Physiol Cell Physiol, March 1, 2006; 290(3): C862 - C872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Hamilton and M. Kiessling DCEBIO stimulates Cl- secretion in the mouse jejunum Am J Physiol Cell Physiol, January 1, 2006; 290(1): C152 - C164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Xu, J. Henriksnas, S. Barone, D. Witte, G. E. Shull, J. G. Forte, L. Holm, and M. Soleimani SLC26A9 is expressed in gastric surface epithelial cells, mediates Cl-/HCO3- exchange, and is inhibited by NH4+ (Report) Am J Physiol Cell Physiol, August 1, 2005; 289(2): C493 - C505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Liedtke, X. Wang, and N. D. Smallwood Role for Protein Phosphatase 2A in the Regulation of Calu-3 Epithelial Na+-K+-2Cl-, Type 1 Co-transport Function J. Biol. Chem., July 8, 2005; 280(27): 25491 - 25498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Krouse, J. F. Talbott, M. M. Lee, N. S. Joo, and J. J. Wine Acid and base secretion in the Calu-3 model of human serous cells Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1274 - L1283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. V. Wu, M. E. Krouse, A. Rustagi, N. S. Joo, and J. J. Wine An Inwardly Rectifying Potassium Channel in Apical Membrane of Calu-3 Cells J. Biol. Chem., November 5, 2004; 279(45): 46558 - 46565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Irokawa, M. E. Krouse, N. S. Joo, J. V. Wu, and J. J. Wine A "virtual gland" method for quantifying epithelial fluid secretion Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L784 - L793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Ciambrone, V. F. Liu, D. C. Lin, R. P. McGuinness, G. K. Leung, and S. Pitchford Cellular Dielectric Spectroscopy: A Powerful New Approach to Label-Free Cellular Analysis J Biomol Screen, September 1, 2004; 9(6): 467 - 480. [Abstract] [PDF]
|
|
|
|
|
|
E. R. Lazarowski, R. Tarran, B. R. Grubb, C. A. van Heusden, S. Okada, and R. C. Boucher Nucleotide Release Provides a Mechanism for Airway Surface Liquid Homeostasis J. Biol. Chem., August 27, 2004; 279(35): 36855 - 36864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. R. Gawenis, K. T. Boyle, B. A. Palmer, N. M. Walker, and L. L. Clarke Lateral intercellular space volume as a determinant of CFTR-mediated anion secretion across small intestinal mucosa Am J Physiol Gastrointest Liver Physiol, June 1, 2004; 286(6): G1015 - G1023. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Shcheynikov, K. H. Kim, K.-m. Kim, M. R. Dorwart, S. B. H. Ko, H. Goto, S. Naruse, P. J. Thomas, and S. Muallem Dynamic Control of Cystic Fibrosis Transmembrane Conductance Regulator Cl-/HCO3- Selectivity by External Cl- J. Biol. Chem., May 21, 2004; 279(21): 21857 - 21865. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Fernandez-Salazar, P. Pascua, J. J. Calvo, M. A. Lopez, R. M. Case, M. C. Steward, and J. I. San Roman Basolateral anion transport mechanisms underlying fluid secretion by mouse, rat and guinea-pig pancreatic ducts J. Physiol., April 15, 2004; 556(2): 415 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Rungroj, M. A. J. Devonald, A. W. Cuthbert, F. Reimann, V. Akkarapatumwong, P.-t. Yenchitsomanus, W. M. Bennett, and F. E. Karet A Novel Missense Mutation in AE1 Causing Autosomal Dominant Distal Renal Tubular Acidosis Retains Normal Transport Function but Is Mistargeted in Polarized Epithelial Cells J. Biol. Chem., April 2, 2004; 279(14): 13833 - 13838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Dubin, S. K. Robinson, and J. H. Widdicombe Secretion of lactoferrin and lysozyme by cultures of human airway epithelium Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L750 - L755. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Zsembery, J. A. Fortenberry, L. Liang, Z. Bebok, T. A. Tucker, A. T. Boyce, G. M. Braunstein, E. Welty, P. D. Bell, E. J. Sorscher, et al. Extracellular Zinc and ATP Restore Chloride Secretion across Cystic Fibrosis Airway Epithelia by Triggering Calcium Entry J. Biol. Chem., March 12, 2004; 279(11): 10720 - 10729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. B. Serikov, H. Choi, K. J. Chmiel, R. Wu, and J. H. Widdicombe Activation of Extracellular Regulated Kinases Is Required for the Increase in Airway Epithelial Permeability during Leukocyte Transmigration Am. J. Respir. Cell Mol. Biol., March 1, 2004; 30(3): 261 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ito, M. Son, S. Sato, T. Ishikawa, M. Kondo, S. Nakayama, K. Shimokata, and H. Kume ATP Release Triggered by Activation of the Ca2+-Activated K+ Channel in Human Airway Calu-3 Cells Am. J. Respir. Cell Mol. Biol., March 1, 2004; 30(3): 388 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Son, Y. Ito, S. Sato, T. Ishikawa, M. Kondo, S. Nakayama, K. Shimokata, and H. Kume Apical and Basolateral ATP-Induced Anion Secretion in Polarized Human Airway Epithelia Am. J. Respir. Cell Mol. Biol., March 1, 2004; 30(3): 411 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. B. Serikov, H. Choi, K. Schmiel, C. Skaggs, N.W. Fleming, R. Wu, and J. H. Widdicombe Endotoxin induces leukocyte transmigration and changes in permeability of the airway epithelium via protein-kinase C and extracellular regulated kinase activation Innate Immunity, February 1, 2004; 10(1): 55 - 65. [Abstract] [PDF]
|
|
|
|
|
|
Y. Ito, M. Son, S. Sato, T. Ohashi, M. Kondo, K. Shimokata, and H. Kume Effects of Fluoranthene, a Polycyclic Aromatic Hydrocarbon, on cAMP-Dependent Anion Secretion in Human Airway Epithelia J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 651 - 657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Wine and N. S. Joo Submucosal Glands and Airway Defense Proceedings of the ATS, January 1, 2004; 1(1): 47 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Coakley, B. R. Grubb, A. M. Paradiso, J. T. Gatzy, L. G. Johnson, S. M. Kreda, W. K. O'Neal, and R. C. Boucher Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium PNAS, December 23, 2003; 100(26): 16083 - 16088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Szkotak, S. F. P. Man, and M. Duszyk The Role of the Basolateral Outwardly Rectifying Chloride Channel in Human Airway Epithelial Anion Secretion Am. J. Respir. Cell Mol. Biol., December 1, 2003; 29(6): 710 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Cobb, L. Fan, T. E. Kovacs, E. J. Sorscher, and J. P. Clancy Adenosine Receptors and Phosphodiesterase Inhibitors Stimulate Cl- Secretion in Calu-3 Cells Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): 410 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A W Cuthbert, C T Supuran, and L J MacVinish Bicarbonate-dependent chloride secretion in Calu-3 epithelia in response to 7,8-benzoquinoline J. Physiol., August 15, 2003; 551(1): 79 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zelenina, A. A. Bondar, S. Zelenin, and A. Aperia Nickel and Extracellular Acidification Inhibit the Water Permeability of Human Aquaporin-3 in Lung Epithelial Cells J. Biol. Chem., August 8, 2003; 278(32): 30037 - 30043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Fong, B. E. Argent, W. B. Guggino, and M. A. Gray Characterization of vectorial chloride transport pathways in the human pancreatic duct adenocarcinoma cell line HPAF Am J Physiol Cell Physiol, August 1, 2003; 285(2): C433 - C445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Hamilton, C. A. Syme, and D. C. Devor Molecular Localization of the Inhibitory Arachidonic Acid Binding Site to the Pore of hIK1 J. Biol. Chem., May 2, 2003; 278(19): 16690 - 16697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. Hallows, G. P. Kobinger, J. M. Wilson, L. A. Witters, and J. K. Foskett Physiological modulation of CFTR activity by AMP-activated protein kinase in polarized T84 cells Am J Physiol Cell Physiol, May 1, 2003; 284(5): C1297 - C1308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M Paradiso, R. D Coakley, and R. C Boucher Polarized distribution of HCO3- transport in human normal and cystic fibrosis nasal epithelia J. Physiol., April 1, 2003; 548(1): 203 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Syme, K. L. Hamilton, H. M. Jones, A. C. Gerlach, L. Giltinan, G. D. Papworth, S. C. Watkins, N. A. Bradbury, and D. C. Devor Trafficking of the Ca2+-activated K+ Channel, hIK1, Is Dependent upon a C-terminal Leucine Zipper J. Biol. Chem., February 28, 2003; 278(10): 8476 - 8486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Hug, T. Tamada, and R. J. Bridges CFTR and Bicarbonate Secretion to Epithelial Cells Physiology, February 1, 2003; 18(1): 38 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. Hallows, J. E. McCane, B. E. Kemp, L. A. Witters, and J. K. Foskett Regulation of Channel Gating by AMP-activated Protein Kinase Modulates Cystic Fibrosis Transmembrane Conductance Regulator Activity in Lung Submucosal Cells J. Biol. Chem., January 3, 2003; 278(2): 998 - 1004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Verkman, Y. Song, and J. R. Thiagarajah Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease Am J Physiol Cell Physiol, January 1, 2003; 284(1): C2 - C15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. S. Joo, T. Irokawa, J. V. Wu, R. C. Robbins, R. I. Whyte, and J. J. Wine Absent Secretion to Vasoactive Intestinal Peptide in Cystic Fibrosis Airway Glands J. Biol. Chem., December 20, 2002; 277(52): 50710 - 50715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Fernandez-Fernandez, M. Nobles, A. Currid, E. Vazquez, and M. A. Valverde Maxi K+ channel mediates regulatory volume decrease response in a human bronchial epithelial cell line Am J Physiol Cell Physiol, December 1, 2002; 283(6): C1705 - C1714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Gross and I. Kurtz Structural determinants and significance of regulation of electrogenic Na+-HCO3- cotransporter stoichiometry Am J Physiol Renal Physiol, November 1, 2002; 283(5): F876 - F887. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Tate, G MacGregor, M Davis, J A Innes, and A P Greening Airways in cystic fibrosis are acidified: detection by exhaled breath condensate Thorax, November 1, 2002; 57(11): 926 - 929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Carlin, R. R. Quesnell, L. Zheng, K. E. Mitchell, and B. D. Schultz Functional and molecular evidence for Na+-HCO3- cotransporter in porcine vas deferens epithelia Am J Physiol Cell Physiol, October 1, 2002; 283(4): C1033 - C1044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. S. Joo, Y. Saenz, M. E. Krouse, and J. J. Wine Mucus Secretion from Single Submucosal Glands of Pig. STIMULATION BY CARBACHOL AND VASOACTIVE INTESTINAL PEPTIDE J. Biol. Chem., July 26, 2002; 277(31): 28167 - 28175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ito, S. Sato, M. Son, M. Kondo, H. Kume, K. Takagi, and K. Yamaki Bisphenol A Inhibits Cl- Secretion by Inhibition of Basolateral K+ Conductance in Human Airway Epithelial Cells J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 80 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H Ishiguro, S Naruse, M Kitagawa, T Mabuchi, T Kondo, T Hayakawa, R M Case, and M C Steward Chloride transport in microperfused interlobular ducts isolated from guinea-pig pancreas J. Physiol., February 15, 2002; 539(1): 175 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S K Inglis, L Finlay, S J Ramminger, K Richard, M R Ward, S M Wilson, and R E Olver Regulation of intracellular pH in Calu-3 human airway cells J. Physiol., January 15, 2002; 538(2): 527 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Cobb, F. Ruiz, C. M. King, J. Fortenberry, H. Greer, T. Kovacs, E. J. Sorscher, and J. P. Clancy A2 adenosine receptors regulate CFTR through PKA and PLA2 Am J Physiol Lung Cell Mol Physiol, January 1, 2002; 282(1): L12 - L25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Szkotak, A. M. L. Ng, J. Sawicka, S. A. Baldwin, S. F. P. Man, C. E. Cass, J. D. Young, and M. Duszyk Regulation of K+ current in human airway epithelial cells by exogenous and autocrine adenosine Am J Physiol Cell Physiol, December 1, 2001; 281(6): C1991 - C2002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Gao, J. R. Yankaskas, C. M. Fuller, E. J. Sorscher, S. Matalon, H. J. Forman, and C. J. Venglarik Chlorzoxazone or 1-EBIO increases Na+ absorption across cystic fibrosis airway epithelial cells Am J Physiol Lung Cell Mol Physiol, November 1, 2001; 281(5): L1123 - L1129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Sedlacek, R. W. Carlin, A. K. Singh, and B. D. Schultz Neurotransmitter-stimulated ion transport by cultured porcine vas deferens epithelium Am J Physiol Renal Physiol, September 1, 2001; 281(3): F557 - F570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Grubb, A. J. Pace, E. Lee, B. H. Koller, and R. C. Boucher Alterations in airway ion transport in NKCC1-deficient mice Am J Physiol Cell Physiol, August 1, 2001; 281(2): C615 - C623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Duszyk Regulation of anion secretion by nitric oxide in human airway epithelial cells Am J Physiol Lung Cell Mol Physiol, August 1, 2001; 281(2): L450 - L457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. S. Joo, J. V. Wu, M. E. Krouse, Y. Saenz, and J. J. Wine Optical method for quantifying rates of mucus secretion from single submucosal glands Am J Physiol Lung Cell Mol Physiol, August 1, 2001; 281(2): L458 - L468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Liedtke, D. Cody, and T. S. Cole Differential regulation of Cl{-} transport proteins by PKC in Calu-3 cells Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L739 - L747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Broughman, K. E. Mitchell, R. L. Sedlacek, T. Iwamoto, J. M. Tomich, and B. D. Schultz NH2-terminal modification of a channel-forming peptide increases capacity for epithelial anion secretion Am J Physiol Cell Physiol, March 1, 2001; 280(3): C451 - C458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E Gross, N Abuladze, A Pushkin, I Kurtz, and C U Cotton The stoichiometry of the electrogenic sodium bicarbonate cotransporter pNBC1 in mouse pancreatic duct cells is 2 HCO3-:1 Na+ J. Physiol., March 1, 2001; 531(2): 375 - 382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Bulteau, R. Derand, Y. Mettey, T. Metaye, M. R. Morris, C. M. McNeilly, C. Folli, L. J. V. Galietta, O. Zegarra-Moran, M. M. C. Pereira, et al. Properties of CFTR activated by the xanthine derivative X-33 in human airway Calu-3 cells Am J Physiol Cell Physiol, December 1, 2000; 279(6): C1925 - C1937. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Loffing, B. D. Moyer, D. Reynolds, B. E. Shmukler, S. L. Alper, and B. A. Stanton Functional and molecular characterization of an anion exchanger in airway serous epithelial cells Am J Physiol Cell Physiol, October 1, 2000; 279(4): C1016 - C1023. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Devor, R. J. Bridges, and J. M. Pilewski Pharmacological modulation of ion transport across wild-type and Delta F508 CFTR-expressing human bronchial epithelia Am J Physiol Cell Physiol, August 1, 2000; 279(2): C461 - C479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Syme, A. C. Gerlach, A. K. Singh, and D. C. Devor Pharmacological activation of cloned intermediate- and small-conductance Ca2+-activated K+ channels Am J Physiol Cell Physiol, March 1, 2000; 278(3): C570 - C581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Singh, D. C. Devor, A. C. Gerlach, M. Gondor, J. M. Pilewski, and R. J. Bridges Stimulation of Cl- Secretion by Chlorzoxazone J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 778 - 787. [Abstract] [Full Text]
|
|
|
|
|
|
A. C. Gerlach, N. N. Gangopadhyay, and D. C. Devor Kinase-dependent Regulation of the Intermediate Conductance, Calcium-dependent Potassium Channel, hIK1 J. Biol. Chem., January 7, 2000; 275(1): 585 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Pedarzani, J. Mosbacher, A. Rivard, L. A. Cingolani, D. Oliver, M. Stocker, J. P. Adelman, and B. Fakler Control of Electrical Activity in Central Neurons by Modulating the Gating of Small Conductance Ca2+-activated K+ Channels J. Biol. Chem., March 23, 2001; 276(13): 9762 - 9769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Joiner, R. Khanna, L. C. Schlichter, and L. K. Kaczmarek Calmodulin Regulates Assembly and Trafficking of SK4/IK1 Ca2+-activated K+ Channels J. Biol. Chem., October 5, 2001; 276(41): 37980 - 37985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wulff, G. A. Gutman, M. D. Cahalan, and K. G. Chandy Delineation of the Clotrimazole/TRAM-34 Binding Site on the Intermediate Conductance Calcium-activated Potassium Channel, IKCa1 J. Biol. Chem., August 17, 2001; 276(34): 32040 - 32045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. C. Sun and J. A. Bonanno Expression, localization, and functional evaluation of CFTR in bovine corneal endothelial cells Am J Physiol Cell Physiol, April 1, 2002; 282(4): C673 - C683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Liedtke, R. Papay, and T. S. Cole Modulation of Na-K-2Cl cotransport by intracellular Cl- and protein kinase C-delta in Calu-3 cells Am J Physiol Lung Cell Mol Physiol, May 1, 2002; 282(5): L1151 - L1159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lazrak, U. Thome, C. Myles, J. Ware, L. Chen, C. J. Venglarik, and S. Matalon Alveolar Epithelial Ion and Fluid Transport: cAMP regulation of Cl- and HCO3- secretion across rat fetal distal lung epithelial cells Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L650 - L658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S K Inglis, L Finlay, S J Ramminger, K Richard, M R Ward, S M Wilson, and R E Olver Regulation of intracellular pH in Calu-3 human airway cells J. Physiol., January 15, 2002; 538(2): 527 - 539. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
bl) less hyperpolarized than the reversal potential of the DNDS-sensitive Na+:HCO–3 cotransporter (E revNaHCO3) and HCO–3 is secreted. Activation of K Ca by 1-EBIO hyperpolarizes